Invus Global Management, LLC - Jun 30, 2025 SCHEDULE 13G/A Report for Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share (KLRS)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Invus Public Equities, L.P.
Security
Kalaris Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
KLRS
Shares outstanding
18.8M shares
Disclosed Ownership
283K shares
Ownership
1.5%
Form type
SCHEDULE 13G/A
Date filed
7/29/2025, 01:21 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 1.5% 283K 283K 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 1.5% 283K 283K 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 1.5% 283K 283K 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 1.5% 283K 283K 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 1.5% 283K 283K 0 /s/ Raymond Debbane Raymond Debbane